News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Stephan Dietrich A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2023 |
4
| Stephan Dietrich A (Founder and CEO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Exercised 93,234 options to buy
@ $0.022, valued at
$2.1k
|
|
| 03/17/2023 |
4
| Stephan Dietrich A (CEO and Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 153,000 shares
@ $0 |
|
| 09/30/2022 |
4
| Stephan Dietrich A (CEO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Exercised 750,000 options to buy
@ $0.0011, valued at
$825 |
|
| 01/25/2022 |
4
| Stephan Dietrich A (President and CEO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 306,000 options to buy
@ $1.58, valued at
$483.5k
|
|
| 01/05/2022 |
4
| Stephan Dietrich A (President and CEO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Exercised 42,250 options to buy
@ $0.001, valued at
$42.3 |
|
| 04/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2020 |
4
| Stephan Dietrich A (President and CEO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Gifted 2,547,639 shares
@ $0
Gifted 1,273,819 shares
@ $0
Gifted 1,273,819 shares
@ $0
Gifted 1,273,820 shares
@ $0
Granted 164,925 options to buy
@ $6.92, valued at
$1.1M
|
|
| 06/10/2020 |
4
| Stephan Dietrich A (President and CEO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Bought 1,275 shares
@ $7.7339, valued at
$9.9k
|
|
| 05/26/2020 |
4
| Stephan Dietrich A (President and CEO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Bought 1,250 shares
@ $8.0888, valued at
$10.1k
|
|
| 05/04/2020 |
4
| Stephan Dietrich A (President and CEO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $6, valued at
$60k
|
|
| 07/23/2019 |
SC 13D
| Stephan Dietrich A reports a 34.3% stake in NeuBase Therapeutics, Inc. |
| 07/16/2019 |
4
| Stephan Dietrich A (President and CEO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 2,547,639 shares
@ $0
Granted 3,311,930 options to buy
@ $0.001, valued at
$3.3k
|
|
| 07/16/2019 |
3
| Stephan Dietrich A (President and CEO) has filed a Form 3 on NeuBase Therapeutics, Inc. |
|
|